Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil
NCT ID: NCT06548893
Last Updated: 2024-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
24 participants
INTERVENTIONAL
2022-08-10
2026-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Researchers will compare intervention to control group to see if those who attend the group therapy have better results than control group.
Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig (Twohig et al, 2018).
* Participants will not have any medication adjustment during therapy
* Participants will be assessed 3 times throughout the therapy, plus an assessment in a 6-month follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial
NCT00680602
Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder
NCT02602886
Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder
NCT02955654
Acceptance and Commitment Therapy for Religious OCD
NCT06647589
Short Term Group Therapy for OCD
NCT00229320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Can ACT in groups help decrease the severity of OCD symptoms?
* Can ACT in groups help increase psychological flexibility in this group?
* Can ACT in groups help increase quality of life in this group?
Researchers will compare intervention (n=16) to control group (n=8) to see if those who attend the group therapy have better results than control group.
We will perform an unequal randomization in a 2:1 ratio, in blocks of 6, for allocation to each group. The assessor of the outcomes of interest will be blinded to the group to which the participant was assigned
Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig (Twohig et al, 2018).
* Participants will not have any medication adjustment during therapy
* Participants will be assessed 3 times throughout the therapy, plus an assessment in a 6-month follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group psychotherapy with ACT
16 sessions of group psychotherapy based on ACT + exposure with response prevention (EPR)
Group acceptance and commitment therapy (ACT)
Group psychotherapy based on ACT + EPR
Treatment as usual
Patients will follow their usual treatment, without adding ACT-based group psychotherapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group acceptance and commitment therapy (ACT)
Group psychotherapy based on ACT + EPR
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal do Paraná
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luciana Midori Samezima
Ms
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriela M Ferreira, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal do Paraná
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal Do Paraná
Curitiba, Paraná, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Twohig MP, Abramowitz JS, Smith BM, Fabricant LE, Jacoby RJ, Morrison KL, Bluett EJ, Reuman L, Blakey SM, Ledermann T. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial. Behav Res Ther. 2018 Sep;108:1-9. doi: 10.1016/j.brat.2018.06.005. Epub 2018 Jun 22.
Related Links
Access external resources that provide additional context or updates about the study.
ACT+ERP for OCD: This is a 16-session twice-weekly therapist manual for OCD describing ERP conducted from an ACT framework.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
61795622.3.0000.0096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.